Based on TCGA database, ZNF468 was overexpressed in different cancer types, including bladder cancer (BLCA), Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), glioma (GBM), lung adenocarcinoma (LUAD), breast cancer (BC) and other cancer types (Fig. 1A, B). This evidence concerns the gene ZNF468 and breast carcinoma.